Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Market Cap	78.73B
Revenue (ttm)	106.39B
Net Income (ttm)	4.89B
Shares Out	15.17M
EPS (ttm)	322.00
PE Ratio	16.12
Forward PE	n/a
Dividend	60.00 (1.16%)
Ex-Dividend Date	Dec 27, 2024

Volume	42,221
Average Volume	86,323
Open	5,280.00
Previous Close	5,220.00
Day's Range	5,130.00 - 5,290.00
52-Week Range	4,700.00 - 8,100.00
Beta	-0.18
RSI	45.40
Earnings Date	Mar 14, 2025

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 002800

Financial Performance

In 2024, Sinsin Pharmaceutical's revenue was 106.39 billion, an increase of 3.71% compared to the previous year's 102.59 billion. Earnings were 4.89 billion, an increase of 4.46%.